Evidence map›Paper›PMID 29221962›Full record

ReviewAdvanced drug delivery reviews2018

Drug delivery and tissue engineering to promote wound healing in the immunocompromised host: Current challenges and future directions.

Alexander M Tatara, Dimitrios P Kontoyiannis, Antonios G Mikos

Abstract readReview
In one paragraph

Review in Advanced drug delivery reviews, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Dual-layer microneedles with NO/OBioactive materials · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Discussing the final size and shape of the reconstructed tissues in tissue engineering.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2023
    Review
  8. Review
  9. Porous Se@SiOFrontiers in bioengineering and biotechnology · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Alexander M TataraMedical Scientist Training Program, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, United States; Department of Bioengineering, Rice University, Houston, TX, United States. Electronic address: tatara@bcm.edu.
Dimitrios P KontoyiannisDepartment of Infectious Diseases, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States. Electronic address: dkontoyi@mdanderson.org.
Antonios G MikosDepartment of Bioengineering, Rice University, Houston, TX, United States. Electronic address: mikos@rice.edu.
Rice University · USThe University of Texas MD Anderson Cancer Center · US

Funding

In Situ Hardening Cell-Laden Constructs for Osteochondral Tissue EngineeringR01AR068073 · NIAMS · RICE UNIVERSITY · PI MIKOS, ANTONIOS G. · 2015 to 2019
$1.7M
NIAMS NIH HHS R01 AR068073
6 · The paper itself

Abstract

As regenerative medicine matures as a field, more promising technologies are being translated from the benchtop to the clinic. However, many of these strategies are designed with otherwise healthy hosts in mind and validated in animal models without other co-morbidities. In reality, many of the patient populations benefiting from drug delivery and tissue engineering-based devices to enhance wound healing also have significant underlying immunodeficiency. Specifically, patients suffering from diabetes, malignancy, human immunodeficiency virus, post-organ transplantation, and other compromised states have significant pleotropic immune defects that affect wound healing. In this work, we review the role of different immune cells in the regenerative process, highlight the effect of several common immunocompromised states on wound healing, and discuss different drug delivery strategies for overcoming immunodeficiencies.

Indexed as

Drug Delivery SystemsTissue EngineeringAnimalsHumansImmunocompromised HostWound HealingImmunityImmunodeficientImmunosuppressionInfectionRegenerative medicineTissue engineering

Identifiers

PMID29221962
PMCPMC5988908
OpenAlexW2774122660

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.